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Abstract 
 
Background/Aims. The hepatic clearance of drugs and cholephilic organic anions is stimulated 
by phenobarbital (PB). Our aim was to analyze the effects of PB on the expression of 
hepatocellular bile salt and organic anion transporters. Methods. Male Sprague-Dawley rats 
were treated intraperitoneally with PB (80 mg/kg/d) or saline for 5 days. Transporter 
expression was quantified by northern and western blot analysis and initial uptake rates of 
bromosulphophthalein (BSP) and digoxin were measured in isolated hepatocytes. Results. 
Compared to control rats, PB treatment increased expression of the organic anion transporting 
polypeptide 2 (Oatp2) more than 2fold on the RNA (P<0.05) and protein (P<0.001) levels. 
Expression of Oatp1, Oatp4 and the Na
+
-taurocholate cotransporting polypeptide (Ntcp) was 
unaltered. At the canalicular pole, expression of the bile salt export pump (Bsep) and of the 
multidrug resistance proteins 2 (Mrp2) and 6 (Mrp6) was not significantly changed. Whereas 
hepatocellular BSP uptake was unaffected by PB, digoxin uptake was stimulated 4fold. 
Conclusions. The induction of digoxin uptake by PB correlates with Oatp2 expression. In 
contrast, the lack of increase of Oatp1 and Oatp4 expression is in accordance with unchanged 
BSP uptake. These data challenge the previously held view that PB induces hepatocellular 
BSP uptake systems. 
 
Word count: 199 words 
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Introduction 
 
Bile formation is driven by the continuous vectorial secretion of bile salts and other 
cholephilic organic anions from blood into bile. The transport pathways across hepatocytes are 
mediated by transport proteins at the basolateral and canalicular domains of hepatocytes. On 
the basolateral side, the Na
+
-taurocholate cotransporting polypeptide (Ntcp) represents the 
chief uptake system for conjugated bile salts (1). For sodium-independent bile salt transport, 
at least three members of the family of organic anion transporting polypeptides, Oatp1, Oatp2 
and Oatp4, are expressed at the basolateral membrane of hepatocytes (2,3). Oatp1 represents a 
major uptake system for the cholephilic dye bromosulphophthalein (BSP) but also transports 
other organic compounds including bile salts and numerous drugs (4,5). Oatp2 is a close 
homologue of Oatp1 and transports bile salts, cardiac glycosides and cyclic peptides, however 
BSP transport via Oatp2 is negligible (6-8). Oatp4 transports a variety of organic compounds 
including BSP and bile salts (3,9). 
 
At the canalicular domain of the hepatocyte, two members of the ATP-binding cassette (ABC) 
superfamily of transporters mediate bile salt and organic anion secretion. The bile salt export 
pump (Bsep) is a major canalicular bile salt transporter of rat liver (10). Non-bile salt organic 
anions such as glutathione and glucuronic acid conjugates are substrates of the canalicular 
multidrug resistance protein Mrp2 (11-13). 
 
Studies in humans have shown that phenobarbital (PB) increases the net hepatic clearance of 
the organic anions BSP and bilirubin from plasma (14). In rat studies, PB treatment enhanced 
the transport maximum for the excretion of bilirubin and BSP into bile (15,16). In isolated rat 
hepatocytes, the maximum uptake velocity of BSP was found to be stimulated more than 
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6fold following treatment of rats with PB (17). This effect was attributable neither to the 
induction of the intracellular BSP binding protein ligandin nor to the induction of UDP-
glucuronyltransferase, which increased to 260% and 200% of controls, respectively, indicating 
a direct effect on basolateral BSP transport (17). A direct effect of PB – known to regulate 
expression of phenobarbital-responsive genes in the liver (18,19) –  on basolateral BSP 
transporter expression was postulated. Since Oatp1 can account for approximately 50% of 
total hepatocellular BSP uptake (20,21) and Oatp4 is the second major BSP uptake system in 
rat hepatocytes (3), we investigated whether these carriers are induced by PB. To study 
whether additional, as yet unidentified basolateral BSP uptake systems are induced by PB, we 
measured initial BSP uptake rates in isolated hepatocytes. Our data show that the known 
increase in hepatic BSP clearance that is induced by PB is not a result of increased 
hepatocellular uptake. 
 
N. Hagenbuch et al.  Phenobarbital and hepatic transporters 5 
Materials and Methods 
 
Chemicals 
All chemicals were of the highest degree of purity available and were available from 
commercial sources. Phenobarbital was obtained from Hänseler AG (Herisau, Switzerland). 
 
Animals 
Male Sprague-Dawley rats (150-250 g) were purchased from RCC Ltd. (Füllinsdorf, 
Switzerland) and kept under routine laboratory conditions with free access to standard 
laboratory chow and water. All studies were performed in accordance with the Swiss Federal 
regulations concerning animal care. 
 
Treatments 
Rats were treated with phenobarbital (PB) injected intraperitoneally at a dosage of 80 mg/kg 
body weight for five consecutive days. PB was freshly dissolved in 0.9% (wt/vol) NaCl at a 
concentration of 40 mg/mL prior to each treatment at 11 a.m. The control group was injected 
with 0.9% NaCl alone. Rats were starved on day 5 of the treatment period and were sacrificed 
on day 6 in the morning. 
 
Northern blots 
Total RNA was extracted from rat liver by the acid guanidinium phenol-chloroform 
procedure. Poly (A
+
) RNA was isolated from total RNA using the PolyATtract System 
(Promega Corporation, Madison, WI). 2.5 µg poly (A
+
) RNA were separated by denaturing 
formaldehyde gel electrophoresis and transferred to a Hybond-NX nylon membrane 
(Amersham International PLC, Buckinghamshire, UK). Blots were hybridized with an [-
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32
P]dCTP labelled DNA probe at 60°C over two hours using ExpressHyb solution (Clontech 
Laboratories Inc., Palo Alto, CA). The following cDNA probes were used: Oatp1 (20), Oatp2 
(6), Mrp2 (22), Bsep (10), Ntcp (23), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and cytochrome P450 (CYP) II B1. The Oatp4 probe was obtained by PCR amplification of a 
fragment corresponding to nt 535-790 of the cloned rlst-1 (9) from rat liver cDNA. The 
resulting 0.255 kb amplicon was 100% identical with the published sequence on the 
nucleotide level. 
 
Blots were washed 2 x 10 minutes in 2xSSC/0.1%SDS at room temperature and 1x15 minutes 
in 0.1xSSC/0.1%SDS at 60°C. Membranes were exposed to autoradiography film (Biomax, 
Kodak) and the autoradiographs were quantitated densitometrically with a CAMAG TLC 
Scanner II (Muttenz, Switzerland). 
 
Isolation of microsomes 
Rat liver microsomes were isolated according to Meier et al. (24) and extracted at pH 8.0 as 
described by Kast et al. (25). Protein was determined by a modification of the Lowry 
procedure (26). 
 
Western Blot Analysis 
Microsomes (75-150 µg) were separated using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (27) and processed by standard Western blotting (28). The blots were probed 
with rabbit antisera raised against Oatp1 (5,29), Oatp2 (8), Ntcp (30), Bsep (10), Mrp2 (31) 
and Mrp6 (31) at appropriate dilutions. Bound antibodies were visualized with iodinated 
protein A and subsequent autoradiography. For comparison of expression levels, 
autoradiographs were scanned with a CAMAG TLC Scanner II (Muttenz, Switzerland). 
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Immunofluorescence studies 
Rat livers were fixed by perfusion and semithin cryosections (0.5-1 m) were incubated with 
antisera as described (30). Micrographs were taken with a Zeiss Axiophot epifluorescence 
microscope (Zeiss, Oberkochen, Germany). 
 
Transport assays in isolated rat hepatocytes 
Hepatocytes from PB treated rats (n=2) and control rats (n=2) were isolated by the two step 
collagenase perfusion method (19,20). Viability was > 85% as assessed by trypan blue 
exclusion. Cells (2 x 10
6
) were seeded onto collagen coated 60 mm dishes in 3 ml Williams 
Medium E. After 3 hours, cells were prewashed in 3 x 2 ml NaCl uptake buffer (33). 
Subsequently uptake of [
35
S]-BSP (1 mol/L) and [3H]-digoxin (10 nmol/L) was measured at 
37° C. Uptakes were stopped by removal of the uptake solution and washing of cell 
monolayers in 4 x 3 ml ice-cold uptake buffer. Cells were lysed in 2 ml 1% Triton-X100. 
Protein concentration was measured with the bicinoic acid method as described (34). Triton-
X100 was present in samples and standards at identical concentrations. 1 ml cell lysate was 
dissolved in 10 ml scintillation fluid (Optifluor; Packard Instruments, Meriden, CA) and 
radioactivity was determined in a Packard Tri-Carb 2200 CA liquid scintillation analyzer. 
 
Statistical analysis 
Transporter expression on the RNA and protein levels is shown as the mean  one standard 
deviation for each treatment group. Expression levels between PB treated and saline treated 
control rats were compared using the unpaired Student t test (35). Statistical significance was 
assumed at P < 0.05. 
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Results 
 
The body mass of the PB treated rats averaged 202  18 g (n.s. vs. controls) with a liver mass 
of 9.6  0.8 g (P<0.002 vs. controls) compared to a body mass of 203  9 g and a liver mass of 
7.6  0.1 g in the control group. Expression of cytochrome P450 II B1, known to be induced 
by PB (36), was induced 35fold (Fig. 1). 
  
Effect of phenobarbital on basolateral transport protein expression. For Oatp1, the ratio of 
Oatp1/GAPDH mRNA levels in the PB treated group decreased to 68  33% compared to 
controls (n.s.) (Fig. 1). In western blot analyses, Oatp1 protein levels in the PB group 
amounted to 73  26% of controls (n.s.) (Fig. 2), which is in the range of the PB-induced 
reduction of mRNA levels. A similar decrease was observed for the Na
+
-dependent bile salt 
transporter Ntcp. PB treatment decreased the Ntcp/GAPDH ratio to 47  11% of controls on 
the RNA (n.s.) (Fig. 1) and 51  29% on the protein level (n.s.) (Fig. 2). Hence, although these 
changes did not reach statistical significance, there was a tendency towards downregulation of 
both Oatp1 and Ntcp expression secondary to PB treatment. For Oatp1, this tendency was also 
evident in morphological studies (Fig. 3). No effect of PB treatment was found on the 
expression of Oatp4 (Fig. 1). 
 
In contrast to Oatp1, Ntcp and Oatp4, expression of Oatp2 was stimulated by PB treatment. 
Oatp2 mRNA was increased to 224  91% of controls (P<0.05) relative to GAPDH (Fig. 1). 
On the protein level, an identical degree of Oatp2 stimulation was found in the PB group (223 
 26% compared to controls, P<0.001) (Fig. 2). This PB induced upregulation of Oatp2 was 
most pronounced in the pericentral region of the hepatic lobules. Thus, while in control liver 
basolateral Oatp2 expression was weak or even absent in the innermost layer of perivenous 
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hepatocytes (8), Oatp2 expression was strong throughout zone 3 hepatocytes in the PB treated 
animals (Fig. 3). These results support preferential PB induction in centrilobular hepatocytes 
and indicate a differential effect of PB treatment on the expression of individual basolateral 
organic anion transporters. 
 
Effect of PB on canalicular transport protein expression. Expression of the bile salt export 
pump Bsep was not significantly changed by PB treatment on both the RNA (Bsep/GAPDH 
ratio 180  83% of controls, n.s., Fig. 4) and the protein (82  17% of controls, n.s., Fig. 5) 
levels. For Mrp2, there was a tendency towards increased expression levels on the RNA level, 
although the changes did not reach statistical significance. The Mrp2/GAPDH mRNA ratio in 
the PB group amounted to 152  65% of controls (Fig. 4), whereas Mrp2 protein levels 
averaged 108  23% of controls (Fig. 5). For Mrp6, which has been localized on both the 
lateral and canalicular membrane of rat hepatocytes (31,37), protein levels were not 
significantly different in PB treated rats and amounted to 59  48% of controls (n.s., Fig. 5). 
 
Initial uptake rates of BSP and digoxin in isolated hepatocytes. To correlate expression levels 
of Oatps with transport function, initial uptake rates of BSP and digoxin were measured in 
isolated hepatocytes. As shown in Fig. 6, BSP uptake was unaffected by PB pretreatment 
(controls vs. PB: 72  9 vs. 70  11 pmol/mg protein/30 seconds). In contrast, net digoxin 
uptake over 30 seconds, after subtraction of nonspecific binding at 0 seconds, was stimulated 
4fold in the PB group (controls vs. PB: 83  9 vs. 337  60 fmol/mg protein, P<0.0001). 
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Discussion 
 
This study analyzes the effect of PB treatment of rats upon the expression of organic anion 
transport proteins of the basolateral and canalicular hepatocyte membrane. Expression of 
Oatp1 was moderately downregulated on both the RNA (Fig. 1) and protein (Fig. 2) levels, 
although the changes were not statistically significant. In contrast, expression of Oatp2, a 
major uptake system for xenobiotics, was upregulated 2fold (Figs. 1 and 2) and most 
pronounced in the perivenous region of the hepatic lobules (Fig. 3). The expression of Oatp4 
was not significantly altered by PB treatment (Fig. 1). The Na
+
-dependent bile salt transporter 
Ntcp was moderately downregulated on both the RNA and protein levels (Figs. 1 and 2). At 
the canalicular domain, expression of the multispecific organic anion transporters Mrp2 and 
Mrp6 and of the bile salt export pump Bsep was not significantly influenced by PB treatment 
(Figs. 4 and 5). 
 
To correlate expression levels of Oatp1, Oatp2 and Oatp4 with transport function, we 
measured initial uptake rates of BSP and digoxin in isolated hepatocytes. Whereas digoxin 
uptake was stimulated 4fold, which was in agreement with increased Oatp2 expression, BSP 
uptake was unaffected by PB (Fig. 6). Thus BSP transport data correlated with Oatp1 and 
Oatp4 expression, indicating the predominant role of these two carriers in hepatocellular BSP 
uptake. Importantly, we were unable to reproduce the 6fold increase in BSP uptake reported 
by Potter et al. (17). We conclude that the known increase in hepatic BSP clearance that is 
induced by PB (38-42) is not a result of increased hepatocellular uptake. 
 
The induction of Oatp2 expression could explain the increase in the biliary excretion of 
xenobiotic compounds such as ouabain and digoxin, and of the endogenous hormone 
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thyroxine, that is induced by PB (43-49). Whether Oatp2 accounts for the reported 8fold 
increase in the Vmax of ditekiren uptake in hepatocytes from PB treated rats (50) is unknown 
at present. Because ditekiren uptake was inhibitable by BSP, the involved transporter probably 
also transports BSP and may thus not be identical with Oatp2, which exhibits negligible BSP 
transport activity (8). 
 
Numerous studies have shown an increase in the bile salt-independent fraction of bile flow 
following PB treatment (51,52). A major determinant of bile salt-independent bile flow is the 
canalicular secretion of anionic glutathione and glucuronic acid conjugates (53), substrates of 
the canalicular multispecific organic anion transporter Mrp2. PB treatment did not 
significantly affect Mrp2 expression, confirming previous functional data obtained in cLPM 
vesicles, that showed no effect of PB treatment on the ATP-dependent transport of BSP and 
leukotriene C4 (54). Furthermore, PB has previously been shown to induce Mrp3 but not 
Mrp1 or Mrp2 to a significant level (55,56). Considering the lack of Mrp2 stimulation by PB, 
it is of interest that in the isolated perfused rat liver model the biliary excretion of anionic 
conjugates such as BSP-GSH, bilirubin glucuronide, bromcresol green, eosine and thyroxine 
glucuronide was enhanced following PB treatment (43,48,57). Although speculative at 
present, it is conceivable that the canalicular membrane possesses additional efflux systems 
for organic anions that are selectively induced by PB. This concept is supported by studies in 
cLPM vesicles, that have indicated selective induction of the electrogenic transport of 
glutathione and BSP by PB (54). Furthermore, normal canalicular secretion of bilirubin 
ditaurate has been shown in Mrp2-deficient TR
-
 rats, suggesting the existence of additional 
canalicular organic anion transporters (58). The molecular identity of these additional 
canalicular transporters is unknown at present. 
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In conclusion, this study shows that the previously reported PB induced stimulation of hepatic 
BSP clearance is not attributable to an increase in hepatocellular BSP uptake. Accordingly, 
expression of the two major BSP uptake systems Oatp1 and Oatp4 is unchanged. In contrast, 
Oatp2 expression is stimulated by PB, which is reflected by increased hepatocellular uptake of 
the Oatp2 specific substrate digoxin. At the canalicular membrane, the known stimulation of 
organic anion secretion that is induced by PB is not attributable to increased expression of 
Bsep and Mrp2. It could be a result of protein activation, e.g. phosphorylation, via second 
messenger pathways, or of selective induction of an as yet unidentified canalicular transport 
system for anionic conjugates. 
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Figure legends 
 
Fig. 1:  Northern blot analysis of basolateral transporter expression in phenobarbital treated 
rats compared to saline treated control rats. 2.5 g poly (A+) RNA from rat livers was 
separated by denaturing formaldehyde electrophoresis and transferred to Nylon membranes 
(see ”Materials and Methods”). Following hybridization, the blots were exposed to 
autoradiography film and band intensities were quantitated densitometrically. Transporter 
expression was normalized for GAPDH expression and the densitometric ratios are shown in 
the bar graph (X  SD for each treatment group). Stimulation of the expression of cytochrome 
P450 II B1 by phenobarbital was documented for control purposes. *Statistically significantly 
different from controls 
 
Fig. 2:  Western blot analysis of basolateral transporter expression in phenobarbital treated 
rats compared to saline treated control rats. 75 g of rat liver microsomes were separated by 
SDS-PAGE and transferred to nitrocellulose. Blots were incubated with rabbit antibodies  (see 
”Materials and Methods”) and bound antibodies were visualized with iodinated protein A and 
subsequent autoradiography. Densitometric quantification of the band intensities is shown in 
the bar graph. *Statistically significant from controls. 
 
Fig. 3: Distribution of basolateral organic anion transporters in control (left) and PB treated 
(right) rat liver as demonstrated by indirect immunofluorescence on semithin cryosections. 
Oatp1 (top) displayed a basolateral distribution in control liver with no detectable intensity 
differences throughout the liver acinus. This distribution pattern was not altered by PB 
treatment. In contrast, the basolateral Oatp2 (middle) displayed an uneven distribution of 
immunoreactivity in control liver. Signal strength was high in zone 3 (around the central vein, 
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CV) and decreased towards the portal tracts (PV, portal vein), while the centralmost layer of 
cells was immunonegative. PB treatment resulted in an increased immunoreactivity in zone 3 
but did not alter signal intensity in zone 1 of the liver acinus. Close up views of zone 3 
(pericentral) hepatocytes (bottom) demonstrate that immunoreactivity was increased 
predominantly in the centralmost layer of hepatocytes. 
 
Fig. 4: Northern blot analysis of canalicular transporter expression in phenobarbital treated 
rats compared to saline treated control rats. The densitometric ratios of Mrp2/GAPDH and 
Bsep/GAPDH expression are shown in the bar graph. The PB induced changes did not reach 
statistical significance. 
 
Fig. 5: Western blot analysis of canalicular transporter expression in phenobarbital treated rats 
compared to saline treated control rats. No significant changes of Bsep, Mrp2 and Mrp6 
expression were observed secondary to PB treatment. 
 
Fig. 6: Initial uptake rates of (A) BSP and (B) digoxin in isolated hepatocytes from 
phenobarbital treated (▲) and control (■) rats. Data points represent the mean ± 1 SD of 
triplicate measurements from two separate hepatocyte preparations. 
